Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Psychiatry Res ; 289: 112985, 2020 07.
Article in English | MEDLINE | ID: mdl-32438209

ABSTRACT

BACKGROUND: Our aim is to examine differences in sexual functioning (SF) between patients with drug-naïve first episode psychosis (FEP) and healthy controls (HC). We will also examine correlations between prolactin levels, testosterone levels and psychotic symptomatology with SF from a gender perspective. METHODS: Cross-sectional study. We included 68 FEP patients and 50 HC. A blood sample was extracted. We used the Positive and Negative Syndrome Scale to assess symptom severity, using the five factor structure according to Emsley. The Changes in Sexual Function Questionnaire (CSFQ) was administered. RESULTS: We found significantly better SF in HC than in patients (in CSFQ total score (p = 0.032) and in CSFQ Desire (p = 0.032)). A significant correlation between prolactin or testosterone and SF was not observed. We found a negative significant correlation between the disorganised subscale of the EMSLEY and total CSFQ (p = 0.027; r = -0.329), CSFQ Desire (p = 0.028; r = -0.329) and CSFQ Arousal (p = 0.026; r = -0.332) in the patient sample. In a regression model, we found sex (p = 0.003) and disorganized symptoms (p = 0.034) as significant predictors. CONCLUSIONS: We found evidence for better SF in HC than in FEP patients. We could not confirm an association between prolactin or testosterone and SF. Disorganized symptomatology could be a relevant factor in SF.


Subject(s)
Prolactin/blood , Psychotic Disorders/blood , Psychotic Disorders/diagnosis , Sex Characteristics , Sexual Dysfunction, Physiological/blood , Sexual Dysfunction, Physiological/diagnosis , Adolescent , Adult , Biomarkers/blood , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Psychotic Disorders/epidemiology , Sexual Dysfunction, Physiological/epidemiology , Surveys and Questionnaires , Young Adult
2.
Actas Esp Psiquiatr ; 30(6): 350-7, 2002.
Article in Spanish | MEDLINE | ID: mdl-12487945

ABSTRACT

INTRODUCTION: The pilot study of the Individualized Service Program for people with Severe Mental Disorders (ISP-SMD) consists of the implementation of case management services in Catalonia. METHODOLOGY: The ISP-SMD has been implemented in two health care sectors and will be expanded to the rest of Catalonia in the next years. The program serves people with persistent mental disorders who have serious social or family problems and/or who have inadequate mental health service use (high use of inpatient services, no use of community services). The ISP-SMD is a community intervention program that focuses its activities on direct care and coordination between services. Thirty patients have been included in the evaluation. RESULTS: The results of the pilot study have shown that, compared to the year before entering the program, the patients show better clinical status, they decrease their unmet need level, they have more appropriate use of health services and have lower treatment costs. Satisfaction of the patients, family members and professionals with the program is very high. CONCLUSION: It is possible to adapt and implement case management services in Catalonia. When implemented, they improve patient quality of life.


Subject(s)
Case Management , Community Mental Health Services/organization & administration , Mental Disorders/therapy , Adult , Female , Humans , Male , Patient Satisfaction , Pilot Projects , Program Evaluation , Severity of Illness Index , Spain
3.
Trastor. adict. (Ed. impr.) ; 3(n.mono.1): 38-43, 2001. tab
Article in Es | IBECS | ID: ibc-23323

ABSTRACT

Objetivo: se realiza un estudio de seguimiento de 91 pacientes en programa de deshabituación con naltrexona tras antagonización rápida de opiáceos. Material y métodos: fue evaluada la retención de 91 pacientes a las 24 horas del alta del tratamiento de desintoxicación así como la retención a los 3 y 6 meses. Se analizan las variables sociodemográficas, de historia de consumo, clínicas y de tratamiento asociadas a la retención en los diferentes momentos de medida. Resultados: las cifras de retención son del 85,6 por ciento (77/91) a las 24 horas, 60,4 por ciento (55/91) a los 3 meses y 59,3 por ciento (54/91) a los 6 meses. Estas cifras difieren significativamente de las aportadas por otros estudios realizados en el mismo ámbito. Conclusiones: las variables que sugieren retención son preferentemente las relacionadas con un mayor período del consumo de heroína y una experiencia previa en programas de naltrexona. (AU)


Subject(s)
Female , Male , Humans , Naltrexone/administration & dosage , Opioid-Related Disorders/drug therapy , Behavior, Addictive/drug therapy , Heroin Dependence/drug therapy , Drug Monitoring/methods , Patient Discharge/statistics & numerical data , Treatment Outcome , Clinical Protocols , Drug Administration Schedule
SELECTION OF CITATIONS
SEARCH DETAIL